Four Top Medical Device Stocks That Are Takeover Candidates

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

The medical device segment has long been one of consolidation and mergers. The incredibly intense competition within a field that is growing exponentially as the global population ages almost makes it a requirement. The Federal Trade Commission (FTC) is already in chambers considering the Zimmer Holdings Inc. (NYSE: ZMH) $13.35 billion deal to merge with Biomet. The European Union has already said they will have a decision on the deal by July 9.

Hey, check out all the engineering jobs. Post your resume today!

Back to news